Nachum Kaplan
Corporate Officer/Principal bei Tel-Aviv University
Aktive Positionen von Nachum Kaplan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Corporate Officer/Principal | 21.04.2010 | - |
Karriereverlauf von Nachum Kaplan
Ehemalige bekannte Positionen von Nachum Kaplan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Affinium Pharmaceuticals Ltd.
Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2013 | - |
Corporate Officer/Principal | 21.04.2010 | 01.10.2013 |
Ausbildung von Nachum Kaplan
Tel-Aviv University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 2 |
Israel | 2 |
Operativ
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Affinium Pharmaceuticals Ltd.
Affinium Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Affinium Pharmaceuticals Ltd. is a holding company, which engages in the provision of clinical development of antibacterial. It specializes in hte development of antibiotics that targets the bacterial fatty acid synthesis pathway. It focuses on small molecule antibacterials targeting FabI, an essential enzyme in the bacterial fatty acid cycle. The company was founded in 2000 and is headquartered in Austin, TX. | Health Technology |
- Börse
- Insiders
- Nachum Kaplan
- Erfahrung